Hye-Rin Kang1, Jun Yeun Cho1, Sang Hoon Lee1, Yeon Joo Lee1, Jong Sun Park1, Young-Jae Cho1, Ho Il Yoon1, Kyung Won Lee2, Jae Ho Lee1, Choon-Taek Lee3. 1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Bundang-Gu, Seongnam, Gyeonggi-do, Republic of Korea. 2. Department of Radiology, Seoul National University Bundang Hospital, Bundang-Gu, Seongnam, Gyeonggi-do, Republic of Korea. 3. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Bundang-Gu, Seongnam, Gyeonggi-do, Republic of Korea. Electronic address: ctlee@snu.ac.kr.
Abstract
INTRODUCTION: The incidence of lung cancer among never-smokers has been increasing rapidly. The U. S. National Lung Screening Trial and the NELSON trial showed that screening using low-dose computerized tomography (LDCT) effectively reduced lung cancer mortality among heavy smokers. However, its effectiveness in never-smokers has not been well investigated. This study investigated the role of LDCT in lung cancer screening among never-smokers. METHODS: The study was designed as a single-center, retrospective cohort study. We analyzed the data on patients who underwent LDCT screening between May 2003 and June 2016. Nodules detected by computerized tomography were classified according to the Lung Imaging Reporting and Data System criteria. The detection rate and lung cancer outcomes (type of cancer, staging of lung cancer, and mortality) according to smoking history were determined. RESULTS: Of the 28,807 enrolled patients, 12,176 were never-smokers; of these patients, 7744 (63.6%) were women and 1218 (10.0%) were found to have lung nodules. Overall, lung cancer was diagnosed in 55 never-smokers (0.45%). In contrast, lung cancer was diagnosed in 143 (0.86%) of the 16,631 ever-smokers. Of the never-smokers with lung cancer, 51 (92.7%) presented with stage I disease, and all patients had adenocarcinomas. CONCLUSIONS: In the never-smoker population, LDCT screening helped to detect a significant number of lung cancers. Most of these lung cancers were detected at a very early stage. The positive results of the National Lung Screening Trial in the United States and the NELSON trial may have established the value of LDCT screening for heavy smokers, but future research should consider the value of using LDCT screening in the never-smoker population.
INTRODUCTION: The incidence of lung cancer among never-smokers has been increasing rapidly. The U. S. National Lung Screening Trial and the NELSON trial showed that screening using low-dose computerized tomography (LDCT) effectively reduced lung cancer mortality among heavy smokers. However, its effectiveness in never-smokers has not been well investigated. This study investigated the role of LDCT in lung cancer screening among never-smokers. METHODS: The study was designed as a single-center, retrospective cohort study. We analyzed the data on patients who underwent LDCT screening between May 2003 and June 2016. Nodules detected by computerized tomography were classified according to the Lung Imaging Reporting and Data System criteria. The detection rate and lung cancer outcomes (type of cancer, staging of lung cancer, and mortality) according to smoking history were determined. RESULTS: Of the 28,807 enrolled patients, 12,176 were never-smokers; of these patients, 7744 (63.6%) were women and 1218 (10.0%) were found to have lung nodules. Overall, lung cancer was diagnosed in 55 never-smokers (0.45%). In contrast, lung cancer was diagnosed in 143 (0.86%) of the 16,631 ever-smokers. Of the never-smokers with lung cancer, 51 (92.7%) presented with stage I disease, and all patients had adenocarcinomas. CONCLUSIONS: In the never-smoker population, LDCT screening helped to detect a significant number of lung cancers. Most of these lung cancers were detected at a very early stage. The positive results of the National Lung Screening Trial in the United States and the NELSON trial may have established the value of LDCT screening for heavy smokers, but future research should consider the value of using LDCT screening in the never-smoker population.
Authors: Eric J Burks; Jiarui Zhang; Travis B Sullivan; Xingyi Shi; Jacob M Sands; Shawn M Regis; Brady J McKee; Andrea B McKee; Sherry Zhang; Hanqiao Liu; Gang Liu; Avrum Spira; Jennifer Beane; Marc E Lenburg; Kimberly M Rieger-Christ Journal: Cancer Treat Res Commun Date: 2021-11-10
Authors: Alexandra Panina; Dilyara Kaidarova; Zhamilya Zholdybay; Akmaral Ainakulova; Jandos Amankulov; Dias Toleshbayev; Zhanar Zhakenova; Arman Khozhayev Journal: J Prev Med Public Health Date: 2022-04-14
Authors: Alka M Kanaya; Ann W Hsing; Sela V Panapasa; Namratha R Kandula; Maria Rosario G Araneta; Daichi Shimbo; Paul Wang; Scarlett L Gomez; Jinkook Lee; K M Venkat Narayan; Marjorie K L Mala Mau; Sonali Bose; Martha L Daviglus; Frank B Hu; Nadia Islam; Chandra L Jackson; Merle Kataoka-Yahiro; John S K Kauwe; Simin Liu; Grace X Ma; Tung Nguyen; Latha Palaniappan; V Wendy Setiawan; Chau Trinh-Shevrin; Janice Y Tsoh; Dhananjay Vaidya; Barbara Vickrey; Thomas J Wang; Nathan D Wong; Sean Coady; Yuling Hong Journal: Ann Intern Med Date: 2022-01-04 Impact factor: 51.598
Authors: Dimitrios Mathios; Jakob Sidenius Johansen; Stephen Cristiano; Jamie E Medina; Jillian Phallen; Klaus R Larsen; Daniel C Bruhm; Noushin Niknafs; Leonardo Ferreira; Vilmos Adleff; Jia Yuee Chiao; Alessandro Leal; Michael Noe; James R White; Adith S Arun; Carolyn Hruban; Akshaya V Annapragada; Sarah Østrup Jensen; Mai-Britt Worm Ørntoft; Anders Husted Madsen; Beatriz Carvalho; Meike de Wit; Jacob Carey; Nicholas C Dracopoli; Tara Maddala; Kenneth C Fang; Anne-Renee Hartman; Patrick M Forde; Valsamo Anagnostou; Julie R Brahmer; Remond J A Fijneman; Hans Jørgen Nielsen; Gerrit A Meijer; Claus Lindbjerg Andersen; Anders Mellemgaard; Stig E Bojesen; Robert B Scharpf; Victor E Velculescu Journal: Nat Commun Date: 2021-08-20 Impact factor: 17.694
Authors: Natasha L Cholowsky; Jesse L Irvine; Justin A Simms; Dustin D Pearson; Weston R Jacques; Cheryl E Peters; Aaron A Goodarzi; Linda E Carlson Journal: Sci Rep Date: 2021-06-07 Impact factor: 4.379
Authors: Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck Journal: Chest Date: 2021-07-13 Impact factor: 9.410